Search Within

Esther Naomi Drill

Formats
  1. Journal Article (52)
  2. Meeting Abstract (43)
  3. Research Letter (2)
Groups
  1. Epidemiology and Biostatistics (97)
  2. Principal Biostatisticians (97)
  3. Department of Medicine (82)
  4. Center for Hematologic Malignancies (55)
  5. Hematologic Malignancies, Division of (54)
  6. Survivorship Research (49)

More Groups

People
  1. Alison Moskowitz (29)
  2. Andrew Zelenetz (28)
  3. Anita Kumar (28)
  4. Steven Horwitz (27)
  5. Ariela Noy (26)
  6. Paul Hamlin (24)

More People

Years
  1. 2025 (4)
  2. 2024 (17)
  3. 2023 (10)
  4. 2022 (10)
  5. 2021 (12)
  6. 2020 (5)

More Years

Publications
  1. Blood (21)
  2. Journal of Clinical Oncology (12)
  3. Haematologica (6)
  4. Clinical Cancer Research (4)
  5. Hematological Oncology (4)
  6. American Journal of Surgical Pathology (3)

More Publications

Publishers
  1. American Society of Hematology (23)
  2. American Society of Clinical Oncology (13)
  3. Elsevier Inc. (9)
  4. American Association for Cancer Research (7)
  5. Ferrata Storti Foundation (6)
  6. Lippincott Williams & Wilkins (5)

More Publishers

Results (97)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Genetic heterogeneity of intrahepatic cholangiocarcinoma: Implications for outcome
    Meeting Abstract

    Song, Y.; Boerner, T.; Drill, E. N.; Shin, P.; Cercek, A.; Kemeny, N. E.; Abou-Alfa, G. K.; Iacobuzio-Donahue, C. A.; Schultz, N.; Walch, H. S.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Characterization of a large cohort of patients with nodal marginal zone lymphoma shows prolonged survival, time-to-treatment, and time-to-transformation
    Meeting Abstract

    Stuver, R.; Drill, E.; Qualls, D.; Okwali, M.; Batlevi, C. L.; Caron, P. C.; Epstein-Peterson, Z. D.; Falchi, L.; Hamilton, A.; Hamlin, P. A.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Molecular profiling across lymphoma subtypes using MSK-impact next generation sequencing
    Meeting Abstract

    Batlevi, C. L.; Drill, E.; Okwali, M.; Ptashkin, R.; Caron, P. C.; Epstein-Peterson, Z. D.; Falchi, L.; Hamilton, A.; Hamlin, P. A.; Horwitz, S. M.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Identifying primary refractory disease and early relapses in peripheral T-cell lymphoma using baseline characteristics, minimal residual disease, and mutational profiling
    Meeting Abstract

    Stuver, R.; Haynie, H.; Epstein-Peterson, Z. D.; Johnson, W. T.; Khan, N.; Mazloom, A.; Moskowitz, A. J.; Drill, E.; Horwitz, S. M.
    Blood (2022)

    Fulltext@MSK | Save
  • Bendamustine in combination with ofatumumab as first line treatment for elderly patients with mantle cell lymphoma: A phase II risk-adapted design
    Journal Article

    Kumar, A.; Casulo, C.; Joffe, E.; Moskowitz, C.; Gerecitano, J.; Moskowitz, A.; Younes, A.; Drullinsky, P.; Drill, E.; Choma, M.; more...
    Leukemia and Lymphoma (2022)

    Fulltext@MSK | Save
  • Comprehensive molecular characterization of gallbladder carcinoma and potential targets for intervention
    Journal Article

    Giraldo, N. A.; Drill, E.; Satravada, B. A.; El Dika, I.; Brannon, A. R.; Dermawan, J.; Mohanty, A.; Ozcan, K.; Chakravarty, D.; Benayed, R.; more...
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save
  • Germline pathogenic variants impact clinicopathology of advanced lung cancer
    Journal Article

    Mukherjee, S.; Bandlamudi, C.; Hellmann, M. D.; Kemel, Y.; Drill, E.; Rizvi, H.; Tkachuk, K.; Khurram, A.; Walsh, M. F.; Zauderer, M. G.; more...
    Cancer Epidemiology Biomarkers and Prevention (2022)

    Fulltext@MSK | Save
  • Prephase rituximab/prednisone therapy and aging-related, proinflammatory cytokine milieu in older, vulnerable patients with newly diagnosed diffuse large B-cell lymphoma
    Journal Article

    Lin, R. J.; Owens, C. N.; Drill, E.; Iannotta, A.; Oliveros, M.; Schick, D. L.; Noy, A.; Gerecitano, J. F.; Drullinsky, P. R.; Caron, P. C.; more...
    Haematologica (2022)

    Fulltext@MSK | Save
  • Applying LymphGen classification to a clinically validated 400-gene targeted next-generation sequencing (NGS) panel in diffuse large B-cell lymphoma (DLBCL)
    Meeting Abstract

    Zhu, M.; Drill, E.; Joffe, E.; Arcila, M.; Dogan, A.
    Modern Pathology (2022)

    Fulltext@MSK | Save
  • Applying lymphgen classification to a clinically validated 400-gene targeted next-generation sequencing (NGS) panel in diffuse large b-cell lymphoma (DLBCL)
    Meeting Abstract

    Zhu, M.; Drill, E.; Joffe, E.; Arcila, M.; Dogan, A.
    Laboratory Investigation (2022)

    Fulltext@MSK | Save